Clinical Trials Browser

Phase 2 × INDUSTRY × edotecarin × Clear all

NCT00067314 2012-01-18

Study in Women With Metastatic Breast Cancer Whose Cancer Has Gotten Worse After Anthracycline and Taxane Therapy

Phase 2 Completed

Breast Neoplasms, Neoplasm Metastasis

NCT00087503 2008-04-01

Intravenous Edotecarin in Patients With Advanced Gastric Cancer That Has Progressed or Recurred After Chemotherapy

Phase 2 Completed

Gastrointestinal

Stomach Neoplasms